GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 05, 2014, inter alia, to consider and take on record the Unaudited Financial Results for the quarter ended on December 31, 2013 with Limited Review done by the Statutory Auditors (Q3).

Source : BSE - >www.bseindia.com

comment COMMENT NOW